Skip to content
10-K

Annual Report

RENOVACARE, INC.

0001171843-22-002186

← back to feed
Filed
Mar 30, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 28, 2022 87.35M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$4.56M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$4.72M
Cash And Equivalents FY 2021 · Dec 31, 2021 $2.85M
Cash And Equivalents FY 2021 · Dec 31, 2020 $7.41M
Cash And Equivalents FY 2021 · Dec 31, 2019 $12.19M
Stockholders Equity FY 2021 · Dec 31, 2021 $2.35M
Stockholders Equity FY 2021 · Dec 31, 2020 $7.08M
Stockholders Equity FY 2021 · Dec 31, 2019 $12.16M
Current Liabilities FY 2021 · Dec 31, 2021 $1.31M
Current Liabilities FY 2021 · Dec 31, 2020 $1.29M
Total Liabilities FY 2021 · Dec 31, 2021 $1.31M
Total Liabilities FY 2021 · Dec 31, 2020 $1.32M
Current Assets FY 2021 · Dec 31, 2021 $3.38M
Current Assets FY 2021 · Dec 31, 2020 $7.98M
Total Assets FY 2021 · Dec 31, 2021 $3.65M
Total Assets FY 2021 · Dec 31, 2020 $8.4M
Sga Expense FY 2021 · Dec 31, 2021 $2.2M
Sga Expense FY 2021 · Dec 31, 2020 $5.54M
Rd Expense FY 2021 · Dec 31, 2021 $3.2M
Rd Expense FY 2021 · Dec 31, 2020 $4.13M
Net Income FY 2021 · Dec 31, 2021 −$4.47M
Net Income FY 2021 · Dec 31, 2020 −$9.55M
Operating Income FY 2021 · Dec 31, 2021 −$5.41M
Operating Income FY 2021 · Dec 31, 2020 −$9.68M
Capex FY 2021 · Dec 31, 2020 $41.27K